Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic endpoints in clinical trials.

Mark A Hlatky1

  • 1Department of Health Research and Policy, Department of Medicine, Stanford University School of Medicine, HRP Redwood Building, Room 150, Stanford, CA 94305-5405, USA. hlatky@stanford.edu

Epidemiologic Reviews
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's health initiative strong and healthy silent atrial fibrillation recording study: Rationale, study design, and baseline data.

American heart journal·2026
Same author

Survival After the First Myocardial Infarction in Older Women: A Prospective Cohort Analysis From the WHI.

Journal of the American Heart Association·2026
Same author

Systemic immune dysregulation in hypertensive disorders of pregnancy persists years after delivery.

Frontiers in immunology·2026
Same author

Reply: Targeted Therapy for Hypertension in Pregnancy: Hemodynamics as a Therapeutic Compass.

JACC. Advances·2026
Same author

Systemic immune dysregulation in hypertensive disorders of pregnancy persists years after delivery.

bioRxiv : the preprint server for biology·2025
Same author

Economic Outcomes and Quality of Life After CABG or PCI for Multivessel Disease: The FAME 3 Trial.

Journal of the American College of Cardiology·2025
Same journal

Systematic review of environmental factors associated with severe fever with thrombocytopenia syndrome occurrences.

Epidemiologic reviews·2026
Same journal

How population-level drug supply data are integrated into health outcomes research: a scoping review.

Epidemiologic reviews·2026
Same journal

Exposure to air pollution and risk of gastrointestinal diseases: a systematic review and meta-analysis of epidemiological evidence.

Epidemiologic reviews·2026
Same journal

Digital solutions for tuberculosis surveillance and control in primary health care: a scoping review.

Epidemiologic reviews·2026
Same journal

Monitoring and evaluation of health disparities for people with disability in low- and middle-income countries: a scoping review.

Epidemiologic reviews·2026
Same journal

Current trends and future prospects of epidemiology of HPV-induced oropharyngeal cancer: a bibliometric analysis.

Epidemiologic reviews·2026
See all related articles

Economic endpoints in clinical trials are growing. Research is refining methods for measuring and analyzing cost data to meet public demand for efficient healthcare.

Area of Science:

  • Health Economics
  • Clinical Trial Methodology

Background:

  • Economic endpoints are increasingly incorporated into randomized clinical trials.
  • The methodologies for measuring and analyzing healthcare costs are still developing within this field.

Purpose of the Study:

  • To highlight the evolving nature of economic endpoint analysis in clinical trials.
  • To underscore the impact of public demand on the advancement of health economic methods.

Main Methods:

  • Analysis of trends in economic endpoint inclusion in clinical trials.
  • Review of current and emerging methods for cost data measurement and analysis.

Main Results:

  • Economic endpoints represent a growing area within clinical trial research.

Related Experiment Videos

  • The field requires further methodological development to meet research and public demands.

    • Conclusions:

    • Advancements in economic endpoint analysis are crucial for demonstrating the value of medical interventions.
    • Clinical trial findings integrating economic data will increasingly inform public health policy and resource allocation.